EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Oral isotretinoin with desloratadine compared with oral isotretinoin alone in the treatment of moderate to severe acne: a randomized, assessor‐blinded study

Neirita Hazarika iD, Piyush Yadav iD, Manmohan Bagri, Divya Chandrasekaran, Riti Bhatia iD

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17129 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Neirita Hazarika und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprosy, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Hauptthemen laut MEDLINE: Isotretinoin, Acne Vulgaris, Loratadine, Severity of Illness Index. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our aim was to measure the effectiveness of oral isotretinoin with desloratadine compared with oral isotretinoin alone in treating moderate to severe acne at a tertiary care teaching hospital in North India. In this study, 90 patients with moderate to severe acne were enrolled to participate based on their fulfilling the inclusion criteria.

Methods

A randomized, assessor‐blinded, parallel‐arm study was conducted. Randomization was done using computer‐generated tables to allocate treatments in a 1:1 ratio. A low‐dose oral isotretinoin at a dose of 0.3 mg/kg/day with tab desloratadine at 5 mg/day was applied to the study group and compared against the same patients going without the dosage when controls were conducted. Follow‐up was at 4, 8, and 12 weeks.

Results

The primary outcome was an improved global acne grading system (GAGS) score and decreased acne lesion count. Secondary outcome: patient satisfaction with treatment. The 90 participants were randomized and 15 participants dropped out of the study, leaving 75 participants for intention to treat analysis ( n = 41, n = 30). At week 12, the GAGS score and acne lesion count between the study and control groups were comparable ( P > 0.05). Pruritus reported was 9.76% in the study versus 33.33% in the control group ( P = 0.018). Also, 53.66% of participants reported “excellent” treatment satisfaction in the study group versus 36.67% in the control group.

Conclusions

The addition of desloratadine to an isotretinoin regimen has a role in reducing disease and therapy‐related pruritus in acne and leads to improved patient satisfaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinAcne VulgarisLoratadineSeverity of Illness IndexDermatologic AgentsPatient SatisfactionHumansFemaleMaleAdministration, OralYoung AdultAdolescentAdultDrug Therapy, CombinationSingle-Blind MethodTreatment OutcomeHistamine H1 Antagonists, Non-Sedating

Stichwörter der Autor:innen

acnedesloratadineisotretinoin

Substanzen

IsotretinoinLoratadinedesloratadineDermatologic AgentsHistamine H1 Antagonists, Non-Sedating

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Leprosy, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

ORCID-Profile: Neirita Hazarika, Piyush Yadav, Riti Bhatia

Zitieren

APA

Hazarika, N., Yadav, P., Bagri, M., Chandrasekaran, D., & Bhatia, R. (2024). Oral isotretinoin with desloratadine compared with oral isotretinoin alone in the treatment of moderate to severe acne: a randomized, assessor‐blinded study. International Journal of Dermatology. https://doi.org/10.1111/ijd.17129

Vancouver

Hazarika N, Yadav P, Bagri M, Chandrasekaran D, Bhatia R. Oral isotretinoin with desloratadine compared with oral isotretinoin alone in the treatment of moderate to severe acne: a randomized, assessor‐blinded study. International Journal of Dermatology. 2024. doi:10.1111/ijd.17129

BibTeX
@article{Hazarika2024,
  author = {Hazarika, Neirita and Yadav, Piyush and Bagri, Manmohan and Chandrasekaran, Divya and Bhatia, Riti},
  title = {Oral isotretinoin with desloratadine compared with oral isotretinoin alone in the treatment of moderate to severe acne: a randomized, assessor‐blinded study},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17129}
}
Kostenlos starten →